Literature DB >> 15681336

Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition?

C Black.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15681336     DOI： 10.1093/rheumatology/keh474

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  [Pulmonary arterial hypertension in collagenoses: clinical features, epidemiology, pathogenesis, diagnosis and treatment].

Authors:  K Ahmadi-Simab; W L Gross
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

2.  Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results.

Authors:  Paola Caramaschi; Alessandro Volpe; Ilaria Tinazzi; Lisa Maria Bambara; Antonio Carletto; Domenico Biasi
Journal:  Rheumatol Int       Date:  2006-09-28       Impact factor: 2.631

Review 3.  Review of bosentan in the management of pulmonary arterial hypertension.

Authors:  Eli Gabbay; John Fraser; Keith McNeil
Journal:  Vasc Health Risk Manag       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.